StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3011% above fair value
$262.21+2.61 (+1.01%)

Close on Nov 16, 2026Market cap $28.85BP/E 26.1Yield –

Quest Diagnostics total assets

Total assets on the balance sheet at the end of each period.

Quest Diagnostics's total assets was $17.22B at Sep 30, 2026. For fiscal 2025 it was $16.23B, up 0.4% from the year before. Over ten years it grew 5.0% a year on average. The highest annual figure on record is $16.23B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$16.23B+0.4%
FY2024Dec 31, 2024$16.15B+15.2%
FY2023Dec 31, 2023$14.02B+9.2%
FY2022Dec 31, 2022$12.84B-5.7%
FY2021Dec 31, 2021$13.61B-3.0%
FY2020Dec 31, 2020$14.03B+9.2%
FY2019Dec 31, 2019$12.84B+16.7%
FY2018Dec 31, 2018$11.00B+4.8%
FY2017Dec 31, 2017$10.50B+4.0%
FY2016Dec 31, 2016$10.10B+1.4%
FY2015Dec 31, 2015$9.96B+1.1%
FY2014Dec 31, 2014$9.86B+10.2%
FY2013Dec 31, 2013$8.95B-3.6%
FY2012Dec 31, 2012$9.28B-0.3%
FY2011Dec 31, 2011$9.31B+9.2%
FY2010Dec 31, 2010$8.53B-0.4%
FY2009Dec 31, 2009$8.56B+1.9%
FY2008Dec 31, 2008$8.40B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$17.22B+6.3%
Q2 FY2026Jun 30, 2026$16.94B+6.1%
Q1 FY2026Mar 31, 2026$16.67B+5.5%
Q4 FY2025Dec 31, 2025$16.23B+0.4%
Q3 FY2025Sep 30, 2025$16.20B+0.6%
Q2 FY2025Jun 30, 2025$15.97B+15.0%
Q1 FY2025Mar 31, 2025$15.80B+13.2%
Q4 FY2024Dec 31, 2024$16.15B+15.2%
Q3 FY2024Sep 30, 2024$16.10B+19.4%
Q2 FY2024Jun 30, 2024$13.88B+3.4%
Q1 FY2024Mar 31, 2024$13.95B+9.1%
Q4 FY2023Dec 31, 2023$14.02B+9.2%
Q3 FY2023Sep 30, 2023$13.48B+2.0%
Q2 FY2023Jun 30, 2023$13.43B+0.8%
Q1 FY2023Mar 31, 2023$12.79B-4.8%
Q4 FY2022Dec 31, 2022$12.84B-5.7%
Q3 FY2022Sep 30, 2022$13.22B-2.6%
Q2 FY2022Jun 30, 2022$13.31B+3.5%
Q1 FY2022Mar 31, 2022$13.44B-3.5%
Q4 FY2021Dec 31, 2021$13.61B-3.0%
Q3 FY2021Sep 30, 2021$13.57B-4.0%
Q2 FY2021Jun 30, 2021$12.86B-1.0%
Q1 FY2021Mar 31, 2021$13.93B+15.6%
Q4 FY2020Dec 31, 2020$14.03B+9.2%
Q3 FY2020Sep 30, 2020$14.14B+17.7%
Q2 FY2020Jun 30, 2020$12.99B+10.5%
Q1 FY2020Mar 31, 2020$12.05B+0.9%
Q4 FY2019Dec 31, 2019$12.84B+16.7%
Q3 FY2019Sep 30, 2019$12.02B+9.4%
Q2 FY2019Jun 30, 2019$11.76B+9.4%
Q1 FY2019Mar 31, 2019$11.94B+11.6%
Q4 FY2018Dec 31, 2018$11.00B+4.8%
Q3 FY2018Sep 30, 2018$10.99B+5.2%
Q2 FY2018Jun 30, 2018$10.75B+5.7%
Q1 FY2018Mar 31, 2018$10.70B+5.8%
Q4 FY2017Dec 31, 2017$10.50B+4.0%
Q3 FY2017Sep 30, 2017$10.44B–
Q2 FY2017Jun 30, 2017$10.17B–
Q1 FY2017Mar 31, 2017$10.11B–
Q4 FY2016Dec 31, 2016$10.10B–

More Quest Diagnostics figures

See a number that looks wrong?